Patent directory · USPTO A61K / A61P
Patents matching “The United States of America, as represented by the Secretary, Department of Health and Human Serv”
1,157 pharma patents match "The United States of America, as represented by the Secretary, Department of Health and Human Serv" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,157 pharmaceutical patents matching "The United States of America, as represented by the Secretary, Department of Health and Human Serv" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 9402889
Live, oral vaccine for protection against Shigella dysenteriae serotype 1
granted -
US 9399672
Hepatitis C virus neutralizing antibody
granted -
US 9394316
Inhibitors of the plasmodial surface anion channel as antimalarials
granted -
US 9394364
Human monoclonal antibodies specific for glypican-3 and use thereof
granted -
US 9394352
Immunogenic POTE peptides and methods of use
granted -
US 9394358
Gene signature for predicting prognosis of patients with solid tumors
granted -
US 9388222
Modified Pseudomonas exotoxin A
granted -
US 9382311
HIV-1 broadly neutralizing antibodies
granted -
US 9364448
Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation
granted -
US 9364557
Fold-back diabody diphtheria toxin immunotoxin and methods of use
granted -
US 9359447
Anti-mesothelin chimeric antigen receptors
granted -
US 9359418
Inhibitors of the T cell-specific alternative p38 activation pathway and methods of use
granted -
US 9358285
Granulysin in immunotherapy
granted -
US 9353353
Virus-like particles (VLPs) prepared from chikungunya virus structural proteins
granted -
US 9346859
Pseudomonas exotoxin A with less immunogenic T cell and/or B cell epitopes
granted -
US 9345748
Anti-SSX-2 T cell receptors and related materials and methods of use
granted -
US 9341619
Hyposialylation disorders
granted -
US 9333251
Vaccine for protection against Shigella sonnei disease
granted -
US 9326950
Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs
granted -
US 9326992
Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA
granted -
US 9328142
Lipopeptide inhibitors of RAS oncoproteins
granted -
US 9328391
Cloning and expression of HIV-1 DNA
granted -
US 9321834
Anti-malarial compositions
granted -
US 9320786
Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
granted